911 related articles for article (PubMed ID: 31356542)
1. Cell-Specific Roles of NLRP3 Inflammasome in Myocardial Infarction.
Takahashi M
J Cardiovasc Pharmacol; 2019 Sep; 74(3):188-193. PubMed ID: 31356542
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting NLRP3 Inflammasome Activity in Acute Myocardial Infarction: A Review of Pharmacologic Agents and Clinical Outcomes.
Buckley LF; Libby P
J Cardiovasc Pharmacol; 2019 Oct; 74(4):297-305. PubMed ID: 31356538
[TBL] [Abstract][Full Text] [Related]
3. NLRP3 Inflammasome in Acute Myocardial Infarction.
Mauro AG; Bonaventura A; Mezzaroma E; Quader M; Toldo S
J Cardiovasc Pharmacol; 2019 Sep; 74(3):175-187. PubMed ID: 31356555
[TBL] [Abstract][Full Text] [Related]
4. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway.
Zhang J; Huang L; Shi X; Yang L; Hua F; Ma J; Zhu W; Liu X; Xuan R; Shen Y; Liu J; Lai X; Yu P
Aging (Albany NY); 2020 Nov; 12(23):24270-24287. PubMed ID: 33232283
[TBL] [Abstract][Full Text] [Related]
5. NLRP3 Inflammasome in Cardioprotective Signaling.
Zuurbier CJ
J Cardiovasc Pharmacol; 2019 Oct; 74(4):271-275. PubMed ID: 31356546
[TBL] [Abstract][Full Text] [Related]
6. The NLRP3 inflammasome in acute myocardial infarction.
Toldo S; Abbate A
Nat Rev Cardiol; 2018 Apr; 15(4):203-214. PubMed ID: 29143812
[TBL] [Abstract][Full Text] [Related]
7. Role of NLRP3 Inflammasome in Cardiac Inflammation and Remodeling after Myocardial Infarction.
Takahashi M
Biol Pharm Bull; 2019; 42(4):518-523. PubMed ID: 30930410
[TBL] [Abstract][Full Text] [Related]
8. Beta-Asarone Alleviates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammatory Response and NLRP3 Inflammasome Mediated Pyroptosis.
Xiao B; Huang X; Wang Q; Wu Y
Biol Pharm Bull; 2020 Jul; 43(7):1046-1051. PubMed ID: 32321872
[TBL] [Abstract][Full Text] [Related]
9. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury.
Sandanger Ø; Ranheim T; Vinge LE; Bliksøen M; Alfsnes K; Finsen AV; Dahl CP; Askevold ET; Florholmen G; Christensen G; Fitzgerald KA; Lien E; Valen G; Espevik T; Aukrust P; Yndestad A
Cardiovasc Res; 2013 Jul; 99(1):164-74. PubMed ID: 23580606
[TBL] [Abstract][Full Text] [Related]
10. Uric acid aggravates myocardial ischemia-reperfusion injury via ROS/NLRP3 pyroptosis pathway.
Shen S; He F; Cheng C; Xu B; Sheng J
Biomed Pharmacother; 2021 Jan; 133():110990. PubMed ID: 33232925
[TBL] [Abstract][Full Text] [Related]
11. The NLRP3 Inflammasome as a Pharmacological Target.
Marchetti C
J Cardiovasc Pharmacol; 2019 Oct; 74(4):285-296. PubMed ID: 31335445
[TBL] [Abstract][Full Text] [Related]
12. The covalent NLRP3-inflammasome inhibitor Oridonin relieves myocardial infarction induced myocardial fibrosis and cardiac remodeling in mice.
Gao RF; Li X; Xiang HY; Yang H; Lv CY; Sun XL; Chen HZ; Gao Y; Yang JS; Luo W; Yang YQ; Tang YH
Int Immunopharmacol; 2021 Jan; 90():107133. PubMed ID: 33168408
[TBL] [Abstract][Full Text] [Related]
13. Kanglexin, a novel anthraquinone compound, protects against myocardial ischemic injury in mice by suppressing NLRP3 and pyroptosis.
Bian Y; Li X; Pang P; Hu XL; Yu ST; Liu YN; Li X; Wang N; Wang JH; Xiao W; Du WJ; Yang BF
Acta Pharmacol Sin; 2020 Mar; 41(3):319-326. PubMed ID: 31645662
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide (LPS) Aggravates High Glucose- and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes.
Qiu Z; He Y; Ming H; Lei S; Leng Y; Xia ZY
J Diabetes Res; 2019; 2019():8151836. PubMed ID: 30911553
[TBL] [Abstract][Full Text] [Related]
15. NLRP3 inflammasome as a key driver of vascular disease.
Takahashi M
Cardiovasc Res; 2022 Jan; 118(2):372-385. PubMed ID: 33483732
[TBL] [Abstract][Full Text] [Related]
16. Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome in Cardiovascular Disorders.
Wang Z; Hu W; Lu C; Ma Z; Jiang S; Gu C; Acuña-Castroviejo D; Yang Y
Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2765-2779. PubMed ID: 30571177
[TBL] [Abstract][Full Text] [Related]
17. Calcium-Sensing Receptor on Neutrophil Promotes Myocardial Apoptosis and Fibrosis After Acute Myocardial Infarction via NLRP3 Inflammasome Activation.
Ren Z; Yang K; Zhao M; Liu W; Zhang X; Chi J; Shi Z; Zhang X; Fu Y; Liu Y; Yin X
Can J Cardiol; 2020 Jun; 36(6):893-905. PubMed ID: 32224080
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotective effect of cinnamaldehyde pretreatment on ischemia/ reperfusion injury via inhibiting NLRP3 inflammasome activation and gasdermin D mediated cardiomyocyte pyroptosis.
Luan F; Lei Z; Peng X; Chen L; Peng L; Liu Y; Rao Z; Yang R; Zeng N
Chem Biol Interact; 2022 Dec; 368():110245. PubMed ID: 36341777
[TBL] [Abstract][Full Text] [Related]
19. The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation.
Martínez GJ; Celermajer DS; Patel S
Atherosclerosis; 2018 Feb; 269():262-271. PubMed ID: 29352570
[TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase kinase-3β inhibition alleviates activation of the NLRP3 inflammasome in myocardial infarction.
Wang S; Su X; Xu L; Chang C; Yao Y; Komal S; Cha X; Zang M; Ouyang X; Zhang L; Han S
J Mol Cell Cardiol; 2020 Dec; 149():82-94. PubMed ID: 32991876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]